Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020


News & Press Releases

News & Press Releases

BIA blog post - Phacilitate Leaders Europe 2019

It can be easy to overlook Europe ‘s CGT significance given the dominant market position of the US and huge growth potential in Asia.

However, developments in healthcare infrastructure, huge clinical trial activity and advancing payer and reimbursement models put Europe at the forefront of the global advanced therapies industry.

Read the full post here


time:matters' review of Phacilitate Leaders Europe 2017

Over 300 people gathered in Berlin for our 3rd Phacilitate Leaders Europe and what a show; not even a power cut could stop the audience from partnering!  It was exciting to see so many new faces joining the community, one of which was time:matters a subsidiary of Lufthansa, the largest airline in Europe. Dr Alina Depkat is leading their initiative into cell therapy and has written a review about her experience as a first-timer at a Phacilitate event.  Here's what she had to say….

Read more here


  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd